May 12, 2021

Serum Institute’s Adar Poonawalla Says Centre’s New Vaccine Policy a “Decisive Change”

Adar Poonawalla Thanks PM For 'Decisive Policy Changes' After Vaccine Aid

Adar Poonawalla applauded PM Modi on behalf of the entire industry for the decisive step.

New Delhi:

The Centre’s new policy allowing all adults to get inoculated for Covid-19 and extending financial aid to the drug-making industry in this context will help vaccine production and distribution in the country, Serum Institute’s Adar Poonawalla has said. Welcoming this change in apparoach, the CEO of one of India’s largest vaccine makers today applauded Prime Minister Narendra Modi on behalf of the entire industry.

Vaccinations were yesterday opened up by the central government for all above 18 from May 1 after PM Modi held a series of meetings over India’s response to record daily surges in Covid cases.

The Centre has also given 100 per cent advance to two of India’s Covid vaccine manufacturers till July, senior sources in the Finance Ministry told NDTV on Monday night.

The advance, calculated as Rs3,000 crore for the Serum Institute (which produces Covishield) and Rs 1,500 crore for Bharat Biotech (which produces Covaxin) will ensure that the two companies get necessary funding to continue and scale up production, the sources said.

The advances come amid concerns that Serum Institute and Bharat Biotech lack the funds to scale up production, purchase raw materials, pay staff, and make and distribute enough doses of the vaccines.

Mr Poonawalla today tweeted in appreciation of these new measures.

States can now also buy doses directly from vaccine-makers in the “liberalised and accelerated Phase 3 strategy of Covid-19 vaccination”. The Centre’s decision came a day after the country reported 2.73 lakh new daily cases in the highest spike since the pandemic broke out in India over a year ago.